Martin Smith
Chief Tech/Sci/R&D Officer bij IDEXX LABORATORIES, INC.
Vermogen: 256 467 $ op 31-03-2024
Profiel
Martin Alexander Smith is currently the Chief Technology Officer & Executive VP at IDEXX Laboratories, Inc. Prior to this, he held the position of Chief Technology Officer at Pall Corp.
from 2014 to 2020.
He also served as the Chief Technology Officer & Vice President at Cytiva from 2020 to 2021.
Dr. Smith's education includes a graduate degree from The University of Reading, an undergraduate degree from the University of Essex, and a doctorate from University College London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IDEXX LABORATORIES, INC.
0.00% | 14-02-2024 | 475 ( 0.00% ) | 256 467 $ | 31-03-2024 |
Actieve functies van Martin Smith
| Bedrijven | Functie | Begin |
|---|---|---|
| IDEXX LABORATORIES, INC. | Chief Tech/Sci/R&D Officer | 01-08-2021 |
Eerdere bekende functies van Martin Smith
| Bedrijven | Functie | Einde |
|---|---|---|
Global Life Sciences Solutions USA LLC
 Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a private company that manufactures therapeutics. The company is based in Marlborough, MA. | Chief Tech/Sci/R&D Officer | 01-07-2021 |
| PALL CORPORATION | Chief Tech/Sci/R&D Officer | 01-08-2020 |
Opleiding van Martin Smith
| The University of Reading | Graduate Degree |
| University of Essex | Undergraduate Degree |
| University College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IDEXX LABORATORIES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a private company that manufactures therapeutics. The company is based in Marlborough, MA. | Health Technology |
